The Dutch Brain Foundation | ClinicalTrials HQ

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Enhancement of Quality of Work And Life	Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyskinesias, Neurologic Manifestations, Nutritional and Metabolic Diseases, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, atactic disorder, non-human animal, basal ganglia disorder, brain disorder, central nervous system disorder, central nervous system malformation, cerebellar ataxia, cerebellar disorder, hereditary disease, hereditary motor and sensory neuropathy, hereditary spastic paraplegia, inborn mitochondrial metabolism disorder, inherited neurodegenerative disorder, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, parkinsonian disorder, peripheral nervous system disorder, polyneuropathy, synucleinopathy	Active, not recruiting	Not applicable	2026-08-14		NCT06573866
No Guts No Glory Probiotics	Body Weight, Body Weight Changes, Insulin Resistance, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, Signs and Symptoms, Weight Gain, glucose metabolism disease, hyperinsulinism, metabolic disease, psychiatric disorder, schizophrenia	Recruiting	Phase 2 / Phase 3	2026-05-26		NCT07606014
Multicenter Registry of Patients With Subarachnoid Hemorrhage	Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Subarachnoid Hemorrhage, Spontaneous, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, subarachnoid hemorrhage, vascular disorder	Recruiting	Not stated	2026-03-19		NCT07482124
Stimulating Amyloid Clearance in Cerebral Amyloid Angiopathy	Nutritional and Metabolic Diseases, amyloidosis, brain disorder, cardiovascular disorder, central nervous system disorder, cerebral amyloid angiopathy, cerebral arterial disease, cerebrovascular disorder, intracranial arterial disease, metabolic disease, nervous system disorder, proteostasis deficiencies, vascular disorder	Enrolling by invitation	Phase 2	2026-02-24		NCT06421532